Tenders Are Invited For Pharmaceutical Products - Delivery Of A Reimbursed Form Of Bevacizumab 100 Mg/ 4 Ml And 400 Mg/ 16 Ml For Intravenous Use

Pharmaceutical Products - Delivery Of A Reimbursed Form Of Bevacizumab 100 Mg/ 4 Ml And 400 Mg/ 16 Ml For Intravenous Use. Object Of These Deliveries: Delivering A Reimbursed Form Of Bevacizumab 100 Mg/ 4 Ml And 400 Mg/ 16 Ml For Intravenous Use. It Is Expected That The Tenderer Will Make Approximately 21 % Of The Estimated Annual Consumption Available As A Medical Sample Annually To The Requests Of The Doctors To Administer The Product Outside Reimbursable Indications (Cf. In Accordance With The Kb Of 11 January 1993 Establishing The Conditions Under Which Medicines For Human Use In The Form Of Samples May Be Handed Over).